Foghorn Therapeutics Inc. Common Stock (FHTX) is a publicly traded Healthcare sector company. As of October 1, 2026, FHTX trades at $1.94 with a market cap of $209.04M and a P/E ratio of -3.61. FHTX moved -45.80% today. Year to date, FHTX is -31.21%; over the trailing twelve months it is -26.99%. Its 52-week range spans $2.94 to $7.61. Analyst consensus is strong buy with an average price target of $11.67. Rallies surfaces FHTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for FHTX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $1.94 |
| Market Cap | $209.04M |
| P/E Ratio | -3.61 |
| EPS | $-0.98 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.61 |
| 52-Week Low | $2.94 |
| Volume | 1.54M |
| Avg Volume | 0 |
| Revenue (TTM) | $36.74M |
| Net Income | $-64.58M |
| Gross Margin | 0.00% |
6 analysts cover FHTX: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.67.